Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 16550
Corporate User License Price USD 750
Corporate User License Price INR 49650
Site License Price USD 500
Site License Price INR 33100
Request a Quote

Report Title

Threshold Pharmaceuticals Inc (THLD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Threshold Pharmaceuticals Inc (THLD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Threshold Pharmaceuticals Inc (THLD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Threshold Pharmaceuticals Inc (THLD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile



Executive Summary

Summary

Threshold Pharmaceuticals Inc (Threshold) is a biotechnology company that discovers and develops tumor-targeted therapies. The company's clinical pipeline includes TH-CR-406, MAESTRO, TH-CR-413, TH-CR-408, TH-IST-4003, TH-IST-4004, TH-CR-410, TH-CR-407 and TH-IST-4001. Its products include evofosfamide, TH-4000 and [18F]-HX4. Threshold's evofosfamide and TH-4000 are under evaluation for the treatment of a variety of tumor types. The company's [18F]-HX4 is an in-licensed positron emission tomography imaging agent for hypoxia. Its clinical trials are used in the treatment of diseases such as soft tissue sarcoma, pancreatic cancer, non-squamous non-small cell lung cancer, advanced melanoma, multiple myeloma and advanced solid tumors. The company operates in Germany. Threshold is headquartered in South San Francisco, California, the US.

Threshold Pharmaceuticals Inc (THLD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Threshold Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Threshold Pharma Enters into Agreement with National Cancer Institute 11

Caris Life Sciences Enters into Agreement with Threshold Pharma 11

Merck Serono Enters Into Co-Development Agreement With Threshold Pharma For TH-302, Cancer Drug 12

Equity Offering 14

Threshold Pharma to Raise USD20 Million in Private Placement of Shares 14

Threshold Pharma Prices Public Offering of Shares and Warrants for USD30 Million 15

Threshold Pharma Files Amended Registration Statement For Public Offering Of Shares For US$15 Million 16

Threshold Pharma Completes Public Offering Of Shares For US$2.6 Million 17

Threshold Pharma Completes Registered Direct Offering Of US$30 Million 18

Acquisition 20

Threshold Pharma to Acquire Molecular Templates 20

Threshold Pharmaceuticals Inc-Key Competitors 22

Key Employees 23

Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

Financial Announcements 25

May 15, 2017: Threshold Pharmaceuticals Reports First Quarter Financial Results 25

Mar 27, 2017: Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results 27

Nov 07, 2016: Threshold Pharmaceuticals Reports Third Quarter Financial Results 29

Aug 01, 2016: Threshold Pharmaceuticals Reports Second Quarter Financial Results 31

May 05, 2016: Threshold Pharmaceuticals Reports First Quarter Financial Results 33

Mar 10, 2016: Threshold Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Year-End 2015 Financial Results 34

Corporate Communications 36

Mar 21, 2016: Threshold Pharmaceuticals Appoints Stew Kroll as Chief Operating Officer 36

Clinical Trials 37

Jun 06, 2016: Threshold Pharmaceuticals Highlights Multiple Presentations on tarloxotinib at the 2016 ASCO Annual Meeting 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Threshold Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Threshold Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Threshold Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9

Threshold Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Threshold Pharma Enters into Agreement with National Cancer Institute 11

Caris Life Sciences Enters into Agreement with Threshold Pharma 11

Merck Serono Enters Into Co-Development Agreement With Threshold Pharma For TH-302, Cancer Drug 12

Threshold Pharma to Raise USD20 Million in Private Placement of Shares 14

Threshold Pharma Prices Public Offering of Shares and Warrants for USD30 Million 15

Threshold Pharma Files Amended Registration Statement For Public Offering Of Shares For US$15 Million 16

Threshold Pharma Completes Public Offering Of Shares For US$2.6 Million 17

Threshold Pharma Completes Registered Direct Offering Of US$30 Million 18

Threshold Pharma to Acquire Molecular Templates 20

Threshold Pharmaceuticals Inc, Key Competitors 22

Threshold Pharmaceuticals Inc, Key Employees 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Threshold Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand